Related Experiment Video
Updated: May 26, 2026
09:42
Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
Published on: November 8, 2013
Correlating changes in lung function with patient outcomes in chronic obstructive pulmonary disease: a pooled
Paul W Jones1, James F Donohue, Jerry Nedelman
1Division of Clinical Science, St George's, University of London, London, UK. pjones@sgul.ac.uk
Respiratory Research
|December 31, 2011
Summary
Improvements in lung function, measured by forced expiratory volume in 1 second (FEV1), correlate with better patient outcomes in COPD. Greater FEV1 increases are linked to improved breathing and reduced exacerbations.
Area of Science:
- Pulmonary Medicine
- Clinical Trials
- Respiratory Research
Background:
- Limited documentation exists on the relationship between lung function improvements and clinical outcomes in COPD.
- This study investigates the correlation between changes in trough forced expiratory volume in 1 second (FEV1) and patient-reported outcomes.
Purpose of the Study:
- To assess the association between changes in FEV1 and patient-reported outcomes in COPD patients.
- To quantify the impact of FEV1 improvements on dyspnea, quality of life, and exacerbation frequency.
Main Methods:
- Pooled data from 3313 participants across three indacaterol studies were analyzed.
- Outcomes including Transition Dyspnoea Index (TDI), St. George's Respiratory Questionnaire (SGRQ) scores, and COPD exacerbation frequency were assessed.
- Generalized linear modeling was employed, adjusting for baseline severity and inhaled corticosteroid use.
Main Results:
- Increasing FEV1 was significantly associated with improvements in TDI and SGRQ scores at all time points (P < 0.001).
- A 100 ml increase in FEV1 at 26 weeks correlated with a 0.46 unit improvement in TDI, 1.3-1.9 point decrease in SGRQ, and a 12% reduction in exacerbation rate.
- Cohort-level correlations between FEV1 changes and outcomes ranged from 0.79-0.95, indicating a strong association.
Conclusions:
- Larger improvements in FEV1 are strongly associated with greater patient-reported benefits in COPD.
- These findings support FEV1 as a meaningful clinical outcome measure in COPD management.
- The relationship between FEV1 and patient outcomes remained consistent after adjusting for baseline covariates.
Related Concept Videos
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:25Pulmonary Function Tests
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: